Exercise therapy to prevent and treat Alzheimer's disease

被引:18
|
作者
Pahlavani, Hamed Alizadeh [1 ]
机构
[1] Farhangian Univ, Dept Phys Educ, Tehran, Iran
来源
关键词
exercise; Alzheimer's disease; aerobic training; anaerobic training; strength training; PHYSICAL-EXERCISE; NEUROTROPHIC FACTOR; AEROBIC EXERCISE; COGNITIVE FUNCTION; OXIDATIVE STRESS; HORMONE IRISIN; KETOGENIC DIET; MOUSE MODEL; HIPPOCAMPUS; NEUROINFLAMMATION;
D O I
10.3389/fnagi.2023.1243869
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is a progressive neurodegenerative disease in the elderly with dementia, memory loss, and severe cognitive impairment that imposes high medical costs on individuals. The causes of AD include increased deposition of amyloid beta (A & beta;) and phosphorylated tau, age, mitochondrial defects, increased neuroinflammation, decreased synaptic connections, and decreased nerve growth factors (NGF). While in animals moderate-intensity exercise restores hippocampal and amygdala memory through increased levels of p-AKT, p-TrkB, and p-PKC and decreased levels of A & beta;, tau phosphorylation, and amyloid precursor proteins (APP) in AD. Aerobic exercise (with an intensity of 50-75% of VO2 max) prevents hippocampal volume reduction, spatial memory reduction, and learning reduction through increasing synaptic flexibility. Exercise training induces the binding of brain-derived neurotrophic factor (BDNF) to TrkB and the binding of NGF to TrkA to induce cell survival and neuronal plasticity. After aerobic training and high-intensity interval training, the increase of VEGF, angiopoietin 1 and 2, NO, tPA, and HCAR1 in cerebral vessels causes increased blood flow and angiogenesis in the cerebellum, motor cortex, striatum, and hippocampus. In the hippocampus, exercise training decreases mitochondrial fragmentation, DRP1, and FIS1, improving OPA1, MFN1, MFN2, and mitochondrial morphology. In humans, acute exercise as an anti-inflammatory condition causes an acute increase in IL-6 and an increase in anti-inflammatory factors such as IL-1RA and IL-10. Moderate-intensity exercise also inhibits inflammatory markers such as IFN-& gamma;, IL-1 & beta;, IL-6, CRP, TNF-& alpha;, sTNFR1, COX-2, and NF-& kappa;B. Aerobic exercise significantly increases plasma levels of BDNF, nerve growth factor, synaptic plasticity, motor activity, spatial memory, and exploratory behavior in AD subjects. Irisin is a myokine released from skeletal muscle during exercise and protects the hippocampus by suppressing A & beta; accumulation and promoting hippocampal proliferation through STAT3 signaling. Therefore, combined exercise training such as aerobic training, strength training, balance and coordination training, and cognitive and social activities seems to provide important benefits for people with AD.
引用
下载
收藏
页数:14
相关论文
共 50 条
  • [21] PHENOTHIAZINES TO TREAT ALZHEIMER'S DISEASE
    Litke, Rachel
    Huang, Bik Tzu
    Gonzalez, Damian
    Rampanana, Martine
    Grimaldi, Nicholas
    Mobbs, Charles
    INNOVATION IN AGING, 2021, 5 : 636 - 636
  • [23] New study suggests combination therapy is needed to treat Alzheimer's disease
    Tipton, Lucy
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (05) : 587 - 587
  • [24] The Mechanism of Exercise Regulating The Autophagy-lysosome Pathway to Prevent Alzheimer's Disease
    Jia Jun
    Zhou Ying-Song
    Lou Qiong
    Chen Xiao-Ping
    Xu Shu-Jun
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 50 (10) : 2314 - 2324
  • [25] To treat or not to treat Alzheimer's disease by the ketogenic diet? That is the question
    Ulamek-Koziol, Marzena
    Pluta, Ryszard
    NEURAL REGENERATION RESEARCH, 2020, 15 (05) : 857 - 858
  • [26] To treat or not to treat Alzheimer's disease by the ketogenic diet? That is the question
    Marzena U?amek-Kozio?
    Ryszard Pluta
    Neural Regeneration Research, 2020, (05) : 857 - 858
  • [27] Gamma Band Neural Stimulation in Humans and the Promise of a New Modality to Prevent and Treat Alzheimer's Disease
    McDermott, Barry
    Porter, Emily
    Hughes, Diarmaid
    McGinley, Brian
    Lang, Mark
    O'Halloran, Martin
    Jones, Marggie
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 65 (02) : 363 - 392
  • [28] Use of memantine to treat Alzheimer's disease
    Gauthier, Serge
    Herrmann, Nathan
    Ferreri, Florian
    Agbokou, Catherine
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (05) : 501 - 502
  • [29] Herbal medicines to treat Alzheimer's disease
    Izzo, Angelo A.
    Capasso, Francesco
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (02) : 47 - 48
  • [30] Targeting Neuroinflammation to Treat Alzheimer’s Disease
    A. Ardura-Fabregat
    E. W. G. M. Boddeke
    A. Boza-Serrano
    S. Brioschi
    S. Castro-Gomez
    K. Ceyzériat
    C. Dansokho
    T. Dierkes
    G. Gelders
    Michael T. Heneka
    L. Hoeijmakers
    A. Hoffmann
    L. Iaccarino
    S. Jahnert
    K. Kuhbandner
    G. Landreth
    N. Lonnemann
    P. A. Löschmann
    R. M. McManus
    A. Paulus
    K. Reemst
    J. M. Sanchez-Caro
    A. Tiberi
    A. Van der Perren
    A. Vautheny
    C. Venegas
    A. Webers
    P. Weydt
    T. S. Wijasa
    X. Xiang
    Y. Yang
    CNS Drugs, 2017, 31 : 1057 - 1082